Rockville, Nov. 08, 2022 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global magnesium sulphate market is estimated at US$ 783.6 million in ...
Intravenous (IV) administration of magnesium sulphate was associated with a reduced risk for in-hospital mortality and 30-day all-cause ICU mortality but possibly extended ICU and hospital stays among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback